Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis
Comparison of Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis
1 other identifier
interventional
26
1 country
1
Brief Summary
The aim of the study is to determine the importance and impact of resistive breathing techniques versus inspiratory hold techniques in patients with chronic bronchitis and specially to find out if there are any changes seen in results measured via the incentive spirometer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedFirst Posted
Study publicly available on registry
September 9, 2022
CompletedSeptember 9, 2022
September 1, 2022
Same day
July 14, 2022
September 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
oxygen saturation
amount of oxygen traveling through your body with your red blood cells. Changes will be assessed at baseline, 3rd week and 6th weeks measured
Changes will be assessed at baseline, 3rd week and 6th weeks measured
Forced expiratory volume in one second
amount of air expired in first one second. Changes will be assessed at baseline, 3rd week and 6th weeks measured
Changes will be assessed at baseline, 3rd week and 6th weeks measured
Forced vital capacity
the total amount of air exhaled during the FEV test. Changes will be assessed at baseline, 3rd week and 6th weeks measured
Changes will be assessed at baseline, 3rd week and 6th weeks measured
FEV1/FVC ratio
the amount of air exhaled in the first second divided by all of the air exhaled during a maximal exhalation.
6 weeks
shortness of breath measured through borge scale of dyspnea
shortness of breath. Changes will be assessed at baseline, 3rd week and 6th weeks measured
Changes will be assessed at baseline, 3rd week and 6th weeks measured
SGRQ questionnaire
how breathing problems effects quality of life . Changes will be assessed at baseline, 3rd week and 6th weeks measured
Changes will be assessed at baseline, 3rd week and 6th weeks measured
Study Arms (2)
Resistive Breathing Training group
EXPERIMENTALThe patients performed two sessions each of 15 minutes session of resistive breathing for four days a week for six weeks using an inspiratory resistive device. Ask patient to take long slow inspirations while breathing through the resistive device
inspiratory hold technique
ACTIVE COMPARATORWith the patient in a comfortable position such as side lying or reclined, the therapist may assist the patient by placing both hands on abdominal area to provide proprioceptive feedback. Then in a relaxed tone of voice therapist instructs the patient to sniff quickly through the nose three times with slow, relaxed exhalations
Interventions
The patients performed two sessions each of 15 minutes session of resistive breathing for four days a week for six weeks using an inspiratory resistive device. Ask patient to take long slow inspirations while breathing through the resistive device
With the patient in a comfortable position such as side lying or reclined, the therapist may assist the patient by placing both hands on abdominal area to provide proprioceptive feedback. Then in a relaxed tone of voice therapist instructs the patient to sniff quickly through the nose three times with slow, relaxed exhalations
Eligibility Criteria
You may qualify if:
- Diagnosed with chronic bronchitis
- Clinically stable patients.
- Both genders.
- Age 45 to 60 years.
- Pink puffers included in this study
- Clients that are involved in research are not allowed for other interventional therapies. They can take their regular medications.
- Patients diagnosed at least 2 years ago with bronchitis.
You may not qualify if:
- Presence of any genetic disorders (cystic fibrosis).
- Recent spinal / chest surgery
- Cardiac issues
- Fractures of vertebra caused by osteoporosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mayo hospital
Lahore, Punjab Province, 53700, Pakistan
Related Publications (5)
Wang G, Hallberg J, Um Bergstrom P, Janson C, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Bergstrom A, Kull I, Linden A, Melen E. Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE. Eur Respir J. 2021 Mar 4;57(3):2002120. doi: 10.1183/13993003.02120-2020. Print 2021 Mar.
PMID: 33184115BACKGROUNDAndelid K, Ost K, Andersson A, Mohamed E, Jevnikar Z, Vanfleteren LEGW, Goransson M. Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis. Respir Res. 2021 Jun 7;22(1):172. doi: 10.1186/s12931-021-01762-4.
PMID: 34098956BACKGROUNDSamaha E, Vierlinger K, Weinhappel W, Godnic-Cvar J, Nohammer C, Koczan D, Thiesen HJ, Yanai H, Fraifeld VE, Ziesche R. Expression Profiling Suggests Loss of Surface Integrity and Failure of Regenerative Repair as Major Driving Forces for Chronic Obstructive Pulmonary Disease Progression. Am J Respir Cell Mol Biol. 2021 Apr;64(4):441-452. doi: 10.1165/rcmb.2020-0270OC.
PMID: 33524306BACKGROUNDBelman MJ, Thomas SG, Lewis MI. Resistive breathing training in patients with chronic obstructive pulmonary disease. Chest. 1986 Nov;90(5):662-9. doi: 10.1378/chest.90.5.662.
PMID: 3769566BACKGROUNDKim HK, Alhammouri MT, Mokhtar YM, Pinsky MR. Estimating left ventricular contractility using inspiratory-hold maneuvers. Intensive Care Med. 2007 Jan;33(1):181-9. doi: 10.1007/s00134-006-0443-8. Epub 2006 Nov 14.
PMID: 17103142BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wajeeha Zia, MSPT
Riphah International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2022
First Posted
September 9, 2022
Study Start
September 1, 2022
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
September 9, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share